Linda Gaudiani
Endocrinology, Diabetes & Metabolism · Greenbrae, CANPI 1730241589
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Eli Lilly accounts for 82.9% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $6,609 and has fallen 98.9% since, to $70 in 2024.
Across 63 payments — averaging $149.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$8K
- Tandem Diabetes Care, Inc.$300
- Lifescan, Inc.$246
- Amgen$196
- Novo Nordisk$149
- Lilly USA, LLC$138
- plus $574 from 11 others
Across 189 payments — averaging $15,447 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2.6M
- AbbVie$179K
- Sanofi US Services Inc.$96K
- Lexicon Pharmaceuticals, Inc.$23K
- Avion Pharmaceuticals$15K
- AstraZeneca$15K
- plus $20K from 4 others
What the payments were for
- Consulting fees$4,05043%
- Speaking & faculty fees$3003%
- Travel & lodging$3,34536%
- Food & beverage$1,62417%
- Education$120%
- Gifts$591%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 15 | $7,789 |
| Tandem Diabetes Care, Inc. | 1 | $300 |
| Lifescan, Inc. | 3 | $246 |
| Amgen | 9 | $196 |
| Novo Nordisk | 6 | $149 |
| Lilly USA, LLC | 6 | $138 |
| Radius Health, Inc. | 6 | $129 |
| Mannkind Corporation | 2 | $102 |
| Lexicon Pharmaceuticals, Inc. | 2 | $101 |
| Companion Medical, Inc. | 5 | $78 |
| Zealand Pharma US, Inc. | 2 | $45 |
| Abbott | 1 | $26 |
| Boehringer Ingelheim | 1 | $23 |
| Insulet Corporation | 1 | $21 |
| Medtronic | 1 | $21 |
| AstraZeneca | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,392 in reported general payments places this provider in the 80th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Other endocrinology, diabetes & metabolism in Greenbrae
- Steven HarrisGreenbrae$564K
- Juan FriasSan Diego$1.4M
- Joselito CabaccanSan Jose$1.4M
- Daniel NadeauNewport Beach$1.2M
- Yehuda HandelsmanTarzana$1M
- Helen BaronRancho Mirage$958K
- Ken FujiokaSan Diego$747K
- Minou TranPico Rivera$663K
- James ChuMonterey$639K
- Anthony HeaneyLos Angeles$588K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.